The company disclosed preliminary results in mid January, but it left out important metrics such as earnings per share for the fourth quarter.
2don MSN
Eli Lilly plans to launch Mounjaro, an anti-diabetes and weight loss drug, in India by 2025. The medication, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback